RXFP3 and Alzheimer disease: Recently Anckaerts et al. [122] demonstrated that interventions that induced premature brain aging and senescence (without excessive cell loss) in the context of AD resulted in significant diminutions in both RXFP3 and GIT2 expression in the retrosplenial cortex.